Search
for

    Sort by

    Research 31–60 of 1000+

    1. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists Pharmacology & therapeutics · 2010 · 105 citations
    2. Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study Cardiovascular Drugs and Therapy · 2024 · 25 citations
    3. Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone Environmental Toxicology and Chemistry · 2013 · 25 citations
    4. Thyroid receptor agonists for the treatment of androgenetic alopecia Bioorganic & Medicinal Chemistry Letters · 2009 · 19 citations
    5. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore<sup>®</sup>, improves telogen effluvium‐associated parameters Journal of Cosmetic Dermatology · 2020 · 11 citations
    6. On the Effect of Estrogen Receptor Agonists and Antagonists on the Mouse Hair Follicle Cycle Journal of Investigative Dermatology · 1998 · 11 citations
    7. Effects of oxytocin receptor agonists on hair growth promotion Scientific Reports · 2024
    8. Lichen Planopilaris Treated With a Peroxisome Proliferator–Activated Receptor γ Agonist Archives of dermatology · 2009 · 105 citations
    9. Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice Psychoneuroendocrinology · 2012 · 42 citations
    10. Failure of Topical Estrogen Receptor Agonists and Antagonists to Alter Murine Hair Follicle Cycling Journal of Investigative Dermatology · 1998 · 8 citations
    11. Risk of Alopecia Areata with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss medRxiv (Cold Spring Harbor Laboratory) · 2025
    12. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics? Archives of dermatological research · 2015 · 60 citations
    13. Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients Journal of The American Academy of Dermatology · 2013 · 33 citations
    14. Effects of transient receptor potential (TRP) channel agonists and antagonists on slowly adapting type II mechanoreceptors in the rat sinus hair follicle Journal of the Peripheral Nervous System · 2009 · 13 citations
    15. Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha microPublication · 2026
    16. Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study Journal of the American Academy of Dermatology · 2025 · 31 citations
    17. Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes Dermatology and Therapy · 2026
    18. Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes Journal of Clinical Medicine · 2026
    19. 732 Treatment with cyclohexyl salicylate, an olfactory receptor 2A4/7 agonist, promotes human hair follicle growth and bulge stem cell progeny expansion Journal of Investigative Dermatology · 2022
    20. Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database Circulation · 2024
    21. Reproduction of the human relevant potency threshold (HRPT) for estrogen receptor alpha agonism in an inference performance screen for ICCVAM’s regulatory scientific confidence framework Frontiers in Toxicology · 2025
    22. An epidermis‐permeable dipeptide is a potential cosmetic ingredient with partial agonist/antagonist activity toward fibroblast growth factor receptors Journal of Cosmetic Dermatology · 2019 · 3 citations
    23. Hair and Scalp Effects of GLP-1 Receptor Agonists in Practice Clinics in Dermatology · 2026
    24. Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study JAAD International · 2026
    25. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome Hormones · 2015 · 61 citations
    26. P.1.g.019 RY-023, an inverse agonist at alpha5 GABAA receptors: the influence on spatial memory and spontaneous locomotor activity European Neuropsychopharmacology · 2008
    27. Respiratory regulation by steroids in newborn rats: a sex‐specific balance between allopregnanolone and progesterone receptors Experimental physiology · 2017 · 17 citations
    28. Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review Cureus · 2024 · 5 citations
    29. Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications Journal of the European Academy of Dermatology and Venereology · 2025
    30. Estrogen Receptor α, but not Estrogen Receptor β, is Involved in the Regulation of the Hair Follicle Cycling as well as the Thickness of Epidermis in Male Mice Journal of Investigative Dermatology · 2002 · 72 citations